Back
Columbia Research Enhanced Value ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
82
REVS
Columbia Research Enhanced Value ETF
Last Price:
$29.13
Seasonality Move:
1.74%
Sell
33
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.94
Seasonality Move:
-8.13%
Buy
82
Columbia Research Enhanced Value ETF (REVS)
is a Buy
Is Columbia Research Enhanced Value ETF a Buy, Sell or Hold?
-
The current Columbia Research Enhanced Value ETF [REVS] share price is $29.15. The Score for REVS is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
REVS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
33
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REVS Stock Price Chart
What is Columbia Research Enhanced Value ETF's stock price today?
-
The Columbia Research Enhanced Value ETF share price today is $29.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REVS is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $32.59The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.
REVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 62.69 | Buy |
| Chaikin Money Flow: | 5196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.82 - 28.9) | Buy |
| Bollinger Bands (100): | (27.22 - 28.38) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.39 | Buy |
| Relative Strength Index (14 RSI): | 42.51 | Sell |
| Chaikin Money Flow: | -433025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.8 - 39.38) | Sell |
| Bollinger Bands (100): | (16.79 - 33.43) | Buy |
REVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.93 | Buy |
| 20-day SMA: | 28.41 | Buy |
| 50-day SMA: | 28.17 | Buy |
| 200-day SMA: | 26.48 | Buy |
| 8-day EMA: | 28.94 | Buy |
| 20-day EMA: | 28.6 | Buy |
| 50-day EMA: | 27.68 | Buy |
| 200-day EMA: | 17.36 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.44 | Sell |
| 20-day SMA: | 37.66 | Sell |
| 50-day SMA: | 32.27 | Buy |
| 200-day SMA: | 17.45 | Buy |
| 8-day EMA: | 37.61 | Sell |
| 20-day EMA: | 34.32 | Sell |
| 50-day EMA: | 23.15 | Buy |
| 200-day EMA: | 7.97 | Buy |
Columbia Research Enhanced Value ETF Earnings Growth & REVS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
Columbia Research Enhanced Value ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||